Jump to main content
Jump to site search


Zwitterionic Diketopyrrolopyrrole for Fluorescence/Photoacoustic Imaging Guided Photodynamic/Photothermal Therapy

Abstract

Dual-modal imaging and dual-modal therapy provides multiple complementary theranositic features. The theranositic agent has favorable renal excretion and low cytotoxicity, making it of great interests in the nanomedical field. Herein, a water-soluble conjugated zwitterionic polymer (DPP-SPMA) with low-fouling and low cytotoxicity was prepared and used for fluorescent/PA imaging guided PTT/PDT therapy. The in vivo imaging results showed that the DPP-SPMA had excellent enhanced permeability and retention effects. The fluorescent imaging demonstrated that the DPP-SPMA was excreted by renal metabolism because the controlled molecular mass was less than the renal filtration threshold. The DPP-SPMA shows a photothermal effect under 730 nm irradiation and an excellent singlet oxygen generation capacity for the PDT therapy under 635 nm irradiation. The high accumulation of DPP-SPMA by passive targeting around the tumor stimulated excellent synergistic photodynamic therapy and photothermal therapy. As a result, the water-soluble zwitterion DPP-SPMA was well suited for fluorescent/PA dual-modal imaging and significant antitumor activity in vivo via synergistic photodynamic therapy and photothermal therapy.

Back to tab navigation

Publication details

The article was received on 11 Feb 2018, accepted on 12 Apr 2018 and first published on 13 Apr 2018


Article type: Paper
DOI: 10.1039/C8PY00244D
Citation: Polym. Chem., 2018, Accepted Manuscript
  •   Request permissions

    Zwitterionic Diketopyrrolopyrrole for Fluorescence/Photoacoustic Imaging Guided Photodynamic/Photothermal Therapy

    W. Deng, Q. Wu, P. Sun, P. Yuan, X. Lu, Q. Fan and W. Huang, Polym. Chem., 2018, Accepted Manuscript , DOI: 10.1039/C8PY00244D

Search articles by author

Spotlight

Advertisements